The STEP 4Life Trial

NACompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

November 1, 2021

Primary Completion Date

November 21, 2022

Study Completion Date

January 2, 2023

Conditions
Alzheimer Disease, At RiskAlzheimer Disease, Protection AgainstDementia
Interventions
BEHAVIORAL

Gamification

Each participant signs a pre-commitment contract agreeing to try their best to achieve their daily step goal. Each week over the 12 week intervention period, participants are endowed 70 points (10/day). Participants are informed they will lose 10 points for each day the step goal is not met. Points are replenished at the start of the week. At the end of the week, if the participant has 40 points or more, he/she will advance one level, or drop one level if they have less than 40 points. The levels include: blue (lowest), bronze, silver, gold, platinum (highest). Each participant begins in the middle (silver). Each participant will also select a spouse, family member, or friend that they see often to serve as a supportive sponsor that receives a weekly email participants progress including points, game level, and average step countThis supportive sponsor will help to enhance social incentives to motivate the individual towards his or her goal.

Trial Locations (1)

19104

Blockley Hall, Philadelphia

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

University of Pennsylvania

OTHER

NCT05069155 - The STEP 4Life Trial | Biotech Hunter | Biotech Hunter